| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BILL | Common Stock | Options Exercise | $44,662 | +3,333 | +350% | $13.40* | 4,286 | 09 Feb 2022 | Direct | |
| transaction | BILL | Common Stock | Sale | $816,585 | -3,333 | -78% | $245.00 | 953 | 09 Feb 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BILL | Stock Option (Right to Buy) | Options Exercise | $0 | -3,333 | -5.9% | $0.000000 | 53,333 | 09 Feb 2022 | Common Stock | 3,333 | $13.40 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | The option vests over a three year period, with 1/3 of the shares vesting on July 3, 2020, and then 1/3 of the shares on each yearly anniversary thereafter until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. |